Vincent Groppi

Center for the Discovery of New Medicines, University of Michigan
Ann Arbor, United States

leticia Ayala

Dennis Dickson

Mayo Clinic
Jacksonville, United States

PAPER Rebeck

Induction of cholesterol efflux in the CNS

Neurobiol. Lipids Vol.3, 1 (2004), Published online February 29, 2004

Ana Viegas

Center for Neuroscience and Cell Biology, University of Coimbra
Coimbra, Portugal

Malcolm Roberts

Eisai

PAPER Feng B, Hu P, Lu SJ, Wang R, Du YF

Effects of APP 5-mer peptide analogue P165 on the synaptic proteins and insulin signal transduction proteins.

Int J Clin Exp Med. 2014;7(3):549-57. Epub 2014 Mar 15 PubMed: 24753747

PAPER Asi YT, Ling H, Ahmed Z, Lees AJ, Revesz T, Holton JL

Neuropathological features of multiple system atrophy with cognitive impairment.

Mov Disord. 2014 Jun;29(7):884-8. Epub 2014 Apr 18 PubMed: 24752994

PAPER Proukakis C, Shoaee M, Morris J, Brier T, Kara E, Sheerin UM, Charlesworth G, Tolosa E, Houlden H, Wood NW, Schapira AH

Analysis of Parkinson's disease brain-derived DNA for alpha-synuclein coding somatic mutations.

Mov Disord. 2014 Jul;29(8):1060-4. Epub 2014 Apr 21 PubMed: 24752924

PAPER

Parkinson disease: Solid tissue levels of α-synuclein could aid diagnosis of PD.

Nat Rev Neurol. 2014 May;10(5) Epub 2014 Apr 22 PubMed: 24752124

PAPER Clairembault T, Kamphuis W, Leclair-Visonneau L, Rolli-Derkinderen M, Coron E, Neunlist M, Hol EM, Derkinderen P

Enteric GFAP expression and phosphorylation in Parkinson's disease.

J Neurochem. 2014 Sep;130(6):805-15. Epub 2014 Jun 6 PubMed: 24749759

PAPER Yokoyama JS, Sirkis DW, Miller BL

C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Am J Neurodegener Dis. 2014;3(1):1-18. Epub 2014 Mar 28 PubMed: 24753999

PAPER Tortelli R, Copetti M, Ruggieri M, Cortese R, Capozzo R, Leo A, D'Errico E, Mastrapasqua M, Zoccolella S, Pellegrini F, Simone IL, Logroscino G

Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis.

Eur J Neurol. 2014 Apr 22; PubMed: 24750431

PAPER Highley JR, Kirby J, Jansweijer JA, Webb PS, Hewamadduma CA, Heath PR, Higginbottom A, Raman R, Ferraiuolo L, Cooper-Knock J, McDermott CJ, Wharton SB, Shaw PJ, Ince PG

Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.

Neuropathol Appl Neurobiol. 2014 Oct;40(6):670-85. PubMed: 24750229

PAPER Raman R, Allen SP, Goodall EF, Kramer S, Ponger LL, Heath PR, Milo M, Hollinger HC, Walsh T, Highley JR, Olpin S, McDermott CJ, Shaw PJ, Kirby J

Gene expression signatures in motor neuron disease fibroblasts reveal dysregulation of metabolism, hypoxia-response and RNA processing functions.

Neuropathol Appl Neurobiol. 2014 Apr 18; PubMed: 24750211